Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Gross Profit (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Gross Profit for 16 consecutive years, with -$993639.0 as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 49.76% to -$993639.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.4 million through Dec 2025, up 21.96% year-over-year, with the annual reading at $25.4 million for FY2025, 21.96% up from the prior year.
  • Gross Profit hit -$993639.0 in Q4 2025 for Cumberland Pharmaceuticals, down from $7.3 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $13.3 million in Q4 2022 to a low of -$2.0 million in Q4 2024.
  • Historically, Gross Profit has averaged $6.6 million across 5 years, with a median of $6.8 million in 2021.
  • Biggest five-year swings in Gross Profit: skyrocketed 165.0% in 2022 and later tumbled 125.28% in 2024.
  • Year by year, Gross Profit stood at $5.0 million in 2021, then surged by 165.0% to $13.3 million in 2022, then tumbled by 41.12% to $7.8 million in 2023, then crashed by 125.28% to -$2.0 million in 2024, then skyrocketed by 49.76% to -$993639.0 in 2025.
  • Business Quant data shows Gross Profit for CPIX at -$993639.0 in Q4 2025, $7.3 million in Q3 2025, and $8.8 million in Q2 2025.